JOHNSTON, Iowa, Dec. 14, 2021 — Pioneer today introduced a diverse new class of 87 corn and soybean seed products to the U.S. market for 2022. These advancements, powered by elite genetics derived from the Corteva Agriscience global germplasm library, build on the strong agronomic characteristics and yield potential of previous classes and launch trailblazing new products.
“Our approach to product development puts farmers’ needs at the forefront. First, our breeders search and screen one of the world’s largest germplasm libraries to develop products capable of performing in a variety of conditions and environments,” said Judd O’Connor, President, U.S. Commercial Business, Corteva Agriscience. “We rigorously test promising hybrids and varieties across multiple years, including pre-commercial IMPACT™ (Intensively Managed Product Advancement Characterization and Testing) trials before choosing only the top-performing products for the Pioneer® brand.”
Exclusive Varieties of Pioneer® brand A-Series Soybeans with the Enlist E3® Trait Announced
The launch of Pioneer® brand A-Series soybeans with the Enlist E3® trait offers new varieties that combine the world-class genetics of Pioneer brand A-Series soybeans, the company’s highest-yielding varieties, with Enlist® technology, the most advanced trait technology available in soybeans. Corteva Agriscience and M.S. Technologies jointly developed and own the transgenic soybean event in Enlist E3 soybeans.
In extensive 2021 testing and trials across geographies, A-Series soybeans with the Enlist E3 trait delivered a 2.0 bu/A yield advantage1 vs. all competitors.
“Pioneer is committed to delivering varieties with Enlist E3 soybean technology,” said Jeff Thompson, Global Soybean Research Lead, Corteva Agriscience. “This aligns with farmer preferences, with Enlist E3 soybeans already at approximately 35% penetration in the U.S. for 2021 — a trend we expect to continue as we progress our plans to introduce the Enlist E3 trait with our A-Series soybeans. The Enlist E3 technology in A-Series soybeans combines a superior weed control system with exclusive Pioneer genetics and is expected to maximize yield potential and profitability on our customers’ farms.”
In all, Pioneer is advancing 37 new soybean products in 2022, most with the Enlist E3 soybean trait, covering a broad range of maturities from 00.5 to 7.0. Pioneer brand A-Series soybeans, which are specifically developed to push yield boundaries and help maximize productivity, feature 32 varieties, including:
Broad New Class of Pioneer® Brand Corn Products Showcase Elite Germplasm
Farmers will have a wider selection of Pioneer® brand corn products than ever before to help drive success in 2022, thanks to this year’s diverse advancing class, which boasts 50 new corn products from 31 new genetic platforms built on elite Pioneer germplasm. All were developed to provide farmers with high yield potential options across myriad field conditions and a full range of maturities, from 69 to 117 CRM.
“This class further diversifies and enhances our product lineup, including multiple advancements in specialty corn markets that most other seed brands do not invest in,” said Luis Verde, North American Corn Product Development Lead, Corteva Agriscience. “At the same time, it’s raising the bar with yield potential, plant health and consistent performance to give farmers confidence that the seed they select will perform when planted on their acres.”
Spanning the past three years, the 2021 class has averaged an impressive 10.4 bu/A yield advantage over competitors in more than 63,000 on-farm and IMPACT™ trial comparisons.2 The 2022 class will build on those achievements with new offerings that include:
Learn more at Pioneer.com/US.
Pioneer, the flagship seed brand of Corteva Agriscience, is the world’s leading developer and supplier of advanced plant genetics, providing high-quality seeds to farmers in more than 90 countries. Pioneer provides agronomic support and services to help increase farmer productivity and profitability and strives to develop sustainable agricultural systems for people everywhere.
Join the discussion and follow Pioneer on Facebook, Twitter, Instagram and YouTube.
About Corteva Agriscience
Corteva, Inc. (NYSE: CTVA) is a publicly traded, global pure-play agriculture company that provides farmers around the world with the most complete portfolio in the industry – including a balanced and diverse mix of seed, crop protection and digital solutions focused on maximizing productivity to enhance yield and profitability. With some of the most recognized brands in agriculture and an industry-leading product and technology pipeline well positioned to drive growth, the company is committed to working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. Corteva Agriscience became an independent public company on June 1, 2019, and was previously the Agriculture Division of DowDuPont. More information can be found at www.corteva.com.
# # #
1 Data is based on an average of 2021 comparisons made in the United States through Dec. 3, 2021. Comparisons are against all competitors, unless otherwise stated, and within +/- 0.3 RM of the competitive brand.
2 Data is based on the average of comparisons 2019-2021 in the U.S. Comparisons are against all competitors, technology segment matched, unless otherwise stated, and within +/- 3 CRM of the competitive brand.
Product responses are variable and subject to any number of environmental, disease and pest pressures. Individual results may vary. Multi-year and multi-location data are a better predictor of future performance. DO NOT USE THIS OR ANY OTHER DATA FROM A LIMITED NUMBER OF TRIALS AS A SIGNIFICANT FACTOR IN PRODUCT SELECTION. Refer to www.pioneer.com/products or contact a Pioneer sales representative or authorized dealer for the latest and complete listing of traits and scores for each Pioneer® brand product. Pioneer® brand products are provided subject to the terms and conditions of purchase which are part of the labeling and purchase documents. Product label instructions must be followed at all times. No offer for sale, sale or use of these products are permitted prior to issuance of the required country, region, or state registrations.
Agrisure® and Agrisure Viptera® are registered trademarks of, and used under license from, a Syngenta Group Company. Agrisure® technology incorporated into these seeds is commercialized under a license from Syngenta Crop Protection AG. Roundup Ready® is a registered trademark used under license from Monsanto Company. Liberty®, LibertyLink® and the Water Droplet Design are trademarks of BASF.
Plenish® high oleic soybeans have an enhanced oil profile and are produced and channeled under contract to specific grain markets. Growers should refer to the Product Use Guide on www.corteva.us/resources/trait-stewardship.html for more information.
Qrome® products are approved for cultivation in the U.S. and Canada. They have also received approval in a number of importing countries, most recently China. For additional information about the status of regulatory authorizations, visit http://www.biotradestatus.com/.
The transgenic soybean event in Enlist E3® soybeans is jointly developed and owned by Corteva Agriscience and M.S. Technologies L.L.C.
™ ® Trademarks of Corteva Agriscience and its affiliated companies.
Cautionary Statement About Forward-Looking Statements
This communication contains forward-looking statements and other estimates within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements and other estimates contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like “guidance”, “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “projects,” “estimates,” “outlook,” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva’s strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, and financial results, as well as expected benefits from, the separation of Corteva from DowDuPont, are forward-looking statements.
Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond Corteva’s control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Corteva’s business, results of operations and financial condition. Some of the important factors that could cause Corteva’s actual results to differ materially from those projected in any such forward-looking statements include: (i) failure to obtain or maintain the necessary regulatory approvals for some of Corteva’s products; (ii) failure to successfully develop and commercialize Corteva’s pipeline; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of Corteva’s biotechnology and other agricultural products; (iv) effect of changes in agricultural and related policies of governments and international organizations; (v) effect of competition and consolidation in Corteva’s industry; (vi) effect of competition from manufacturers of generic products; (vii) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (viii) effect of climate change and unpredictable seasonal and weather factors; (ix) risks related to oil and commodity markets; (x) competitor’s establishment of an intermediary platform for distribution of Corteva's products; (xi) impact of Corteva’s dependence on third parties with respect to certain of its raw materials or licenses and commercialization; (xii) effect of industrial espionage and other disruptions to Corteva’s supply chain, information technology or network systems; (xiii) effect of volatility in Corteva’s input costs; (xiv) failure to realize the anticipated benefits of the internal reorganizations taken by DowDuPont in connection with the spin-off of Corteva and other cost savings initiatives; (xv) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to Corteva; (xvi) failure of Corteva’s customers to pay their debts to Corteva, including customer financing programs; (xvii) increases in pension and other post-employment benefit plan funding obligations; (xviii) risks related to the indemnification obligations of legacy EID liabilities in connection with the separation of Corteva; (xix) effect of compliance with laws and requirements and adverse judgments on litigation; (xx) risks related to Corteva’s global operations; (xxi) failure to effectively manage acquisitions, divestitures, alliances and other portfolio actions; (xxii) risks related to COVID-19; (xxiii) risks related to activist stockholders; (xxiv) Corteva’s intellectual property rights or defend against intellectual property claims asserted by others; (xxv) effect of counterfeit products; (xxvi) Corteva’s dependence on intellectual property cross-license agreements; (xxvii) other risks related to the Separation from DowDuPont; (xxvii) risks related to the Biden executive order Promoting Competition in the American Economy; and (xxix) risks associated with our CEO transition. Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva’s management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement or other estimate, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements or other estimates is included in the “Risk Factors” section of Corteva’s Annual Report on Form 10-K, as modified by subsequent Quarterly Reports on Forms 10-Q and Current Reports on Form 8-K.